Le Lézard
Classified in: Health
Subjects: RCL, PSF, CFG

Updated Food Recall Warning (Allergen) - Wulama brand Fish Tofu and Want Want brand Shake Jelly products recalled due to undeclared allergens


Product photos are available at https://bit.ly/2K1jKyn

OTTAWA, July 27, 2018 /CNW/ - This additional information was identified during Canadian Food Inspection Agency's (CFIA) food safety investigation.

AJ International Trading is recalling Wulama brand Fish Tofu and Want Want brand Shake Jelly products from the marketplace because they may contain egg, sesame, and milk which are not declared on the label. People with an allergy to egg, sesame, or milk should not consume the recalled products described below.

The following products have been sold in Ontario.

Recalled product

 

Brand

Product

Size

UPC

Codes

Wulama (Chinese characters only)

Fish Tofu

95 g

6 936158 282293

All codes where egg and sesame are not declared on the label

Want Want

Shake Jelly (Chocolate)

132 g

6 920658 210443

All codes where milk is not declared on the label

Want Want

Shake Jelly (Coffee)

132 g

6 920658 267119

All codes where milk is not declared on the label

 

What you should do

Check to see if you have recalled products in your home. Recalled products should be thrown out or returned to the store where they were purchased.

If you have an allergy to egg, sesame, or milk, do not consume the recalled products as they may cause a serious or life-threatening reaction.

Background

This recall was triggered by CFIA's test results. The CFIA is conducting a food safety investigation, which may lead to the recall of other products. If other high-risk products are recalled, the CFIA will notify the public through updated Food Recall Warnings.

The CFIA is verifying that industry is removing recalled product from the marketplace.

Reactions

There have been no reported reactions associated with the consumption of these products.

More information

 

SOURCE Canadian Food Inspection Agency (CFIA)


These press releases may also interest you

at 12:20
The "Regenerative Medicine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Regenerative Medicine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented...

at 12:10
The "Diagnostic Imaging Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Diagnostic Imaging Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...

at 12:05
King Faisal Specialist Hospital & Research Centre (KFSH&RC) has achieved a significant milestone in its Robotic Cardiac Surgery Program, which was initiated in February 2019. Within its first year, the program performed 105 cardiac procedures. As of...

at 11:55
The "Infectious Vaccine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Infectious Vaccine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...

at 11:40
The "Musculoskeletal Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Musculoskeletal Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the...

at 11:30
The "Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2016-2024" report has been added to ResearchAndMarkets.com's offering. Fully revised and updated, the report provides details of option and evaluation deals from 2016 to 2024....



News published on and distributed by: